Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease
Clinical trial NCT03077412 · COMPLETED
Trial details
- NCT number
- NCT03077412
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-06
- Primary completion
- 2021-01-20
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.